AC Immune SA expected to post earnings of 3  rappen a share - Earnings Preview

AC Immune SA

24/10/2023 19:32

* AC Immune SA  ACIU.OQ   ACIU.O  is expected to show a rise
in
quarterly revenue when it reports  results 
    * The Lausanne Vaud-based  company is expected to report  a
438.9% increase in revenue to CHF21.2 million from CHF3.93
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for AC Immune SA is for
earnings of 3 rappen per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for AC Immune
SA is
$11​, above​ its last closing price of $2.65. ​​​

Previous quarterly performance (using preferred earnings measure
in Swiss francs). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.19       -0.20      -0.20     Met     -1.4
 Mar. 31 2023  -0.23       -0.23      -0.21     Beat    8.5
 Dec. 31 2022              -0.25      -0.23     Beat    8.7​
 Sep. 30 2022  -0.27       -0.24      -0.16     Beat    33.8
 ​​Jun.        -0.25       -0.23      -0.23     Met     1
 30 2022                                                
 Mar. 31 2022  -0.22       -0.22      -0.23     Missed  -3.8​
 Dec. 31 2021  0.82        0.10       -0.28     Missed  -373.1
 Sep. 30 2021  -0.26       -0.27      -0.22     Beat    19.1
 This summary was machine generated October 24 at 18:31 GMT.  All
figures in Swiss francs  unless otherwise stated